Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study

The comparative efficacy and safety between lenvatinib and hepatic artery infusion chemotherapy (HAIC) in patients with unresectable hepatocellular carcinoma (HCC) is still unclear. This multicenter historical cohort study enrolled 244 patients who were treated with HAIC (n = 173) or lenvatinib (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jaejun, Han, Ji-Won, Sung, Pil-Soo, Lee, Soon-Kyu, Yang, Hyun, Nam, Hee-Chul, Yoo, Sun-Hong, Lee, Hae-Lim, Kim, Hee-Yeon, Lee, Sung-Won, Kwon, Jung-Hyun, Jang, Jeong-Won, Kim, Chang-Wook, Nam, Soon-Woo, Oh, Jung-Suk, Chun, Ho-Jong, Bae, Si-Hyun, Choi, Jong-Young, Yoon, Seung-Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464794/
https://www.ncbi.nlm.nih.gov/pubmed/34575160
http://dx.doi.org/10.3390/jcm10184045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464794/
https://www.ncbi.nlm.nih.gov/pubmed/34575160
http://dx.doi.org/10.3390/jcm10184045

Ejemplares similares